Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

Clicks: 529
ID: 111686
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 3 articles by views in helicobacter

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Omeprazole triple therapies given twice daily for 1 week produce high eradication rates, are well-tolerated, and are associated with high patient compliance. The two most effective therapies were those combining omeprazole, 20 mg, with either amoxicillin, 1 gm, plus clarithromycin, 500 mg, or metron …
Reference Key
t1996helicobactereradication Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lind T;Veldhuyzen van Zanten S;Unge P;Spiller R;Bayerdörffer E;O'Morain C;Bardhan KD;Bradette M;Chiba N;Wrangstadh M;Cederberg C;Idström JP;;
Journal helicobacter
Year 1996
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/9398894
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't female male middle aged Drug Administration Schedule Comparative Study Clinical Trial Randomized Controlled Trial Double-Blind Method Multicenter Study amoxicillin / therapeutic use* clarithromycin / therapeutic use* drug therapy enzyme inhibitors / therapeutic use* pmid:9398894 doi:10.1111/j.1523-5378.1996.tb00027.x t lind s veldhuyzen van zanten j p idström amoxicillin / administration & dosage anti-ulcer agents / administration & dosage anti-ulcer agents / therapeutic use* clarithromycin / administration & dosage combination / administration & dosage combination / therapeutic use* duodenal ulcer / drug therapy* duodenal ulcer / etiology enzyme inhibitors / administration & dosage gastritis / complications gastritis / drug therapy* helicobacter infections / complications helicobacter infections / drug therapy* helicobacter infections / microbiology helicobacter pylori / drug effects* metronidazole / administration & dosage metronidazole / therapeutic use* omeprazole / administration & dosage omeprazole / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.